These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 21385304)

  • 61. Rubella and congenital rubella syndrome control and elimination – global progress, 2012.
    Wkly Epidemiol Rec; 2013 Dec; 88(49):521-7. PubMed ID: 24367837
    [No Abstract]   [Full Text] [Related]  

  • 62. [Update for the standard procedures of diagnosis and therapy in cases of congenital rubella].
    Buffolano W; Filia A; Agnese M; Stronati M; Dicostanzo P
    Pediatr Med Chir; 2013; 35(3):110-7. PubMed ID: 23947110
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating.
    Haas DM; Flowers CA; Congdon CL
    Obstet Gynecol; 2005 Aug; 106(2):295-300. PubMed ID: 16055578
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rubella and pregnancy. ACOG Technical Bulletin Number 171--August 1992.
    Int J Gynaecol Obstet; 1993 Jul; 42(1):60-6. PubMed ID: 8103485
    [No Abstract]   [Full Text] [Related]  

  • 65. [The results of an investigation on the prevalence rate of rubella antibody, history of rubella infection and of vaccination in pregnant women].
    Hirosawa H; Nakamura Y; Watanabe N; Yoneyama K; Date R
    Kansenshogaku Zasshi; 1988 Jul; 62(7):652-6. PubMed ID: 3141526
    [No Abstract]   [Full Text] [Related]  

  • 66. Rubella in the Russian Federation: epidemiological features and control measures to prevent the congenital rubella syndrome.
    Semerikov VV; Lavrentyeva IN; Popov VF; Fletcher MA; Kolotov ME
    Epidemiol Infect; 2000 Oct; 125(2):359-66. PubMed ID: 11117959
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rubella susceptibility and continuing risk of infection in pregnancy.
    Rasul S; Rizvi S; Khurshid M; Rizvi J
    J Pak Med Assoc; 1990 May; 40(5):102-3. PubMed ID: 2115599
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Rubella still a problem in Europe--important that pregnant women have an adequate protection].
    Johansen K; Sjödin M; Westrell-Oskarsson L; Arneborn M; Akerlind B; Forsgren M
    Lakartidningen; 2004 Dec; 101(49):3994-6, 3998-9. PubMed ID: 15633337
    [No Abstract]   [Full Text] [Related]  

  • 69. Risk of perinatal transmission of rubella and parvovirus B19 in Jordanian pregnant women.
    Bdour S
    Vaccine; 2006 Apr; 24(16):3309-12. PubMed ID: 16460842
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serological statuses of pregnant women in an urban Brazilian population before and after the 2008 rubella immunization campaign.
    Avila Moura A; Mello MJG; Correia JB
    Vaccine; 2016 Jan; 34(4):445-450. PubMed ID: 26707222
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rubella surveillance to June 1994: third joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E; Tookey P; Morgan-Capner P; Hesketh L; Brown D; Waight P; Vurdien J; Jones G; Peckham C
    Commun Dis Rep CDR Rev; 1994 Nov; 4(12):R146-52. PubMed ID: 7529090
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Viral infections and pregnancy: rubella].
    Gioannini P
    Minerva Med; 1977 Sep; 68(44):3043-52. PubMed ID: 917323
    [No Abstract]   [Full Text] [Related]  

  • 73. Controlling rubella and preventing congenital rubella syndrome – global progress, 2009.
    Wkly Epidemiol Rec; 2010 Oct; 85(42):413-8. PubMed ID: 20949700
    [No Abstract]   [Full Text] [Related]  

  • 74. [Rubella seroprevalence in Tunisian childbearing women two years after vaccination program introduction].
    Chaabouni M; Messadi F; Fki L; M Z; Hammami A; Karray H
    Pathol Biol (Paris); 2012 Jun; 60(3):170-3. PubMed ID: 22578467
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [How does one vaccinate women against rubella?].
    MMW Fortschr Med; 2016 May; 158(10):28. PubMed ID: 27221415
    [No Abstract]   [Full Text] [Related]  

  • 76. The risk factors of exposure to rubella among pregnant women in Zaria 2013.
    Gubio AB; Mamman AI; Abdul M; Olayinka AT
    Pan Afr Med J; 2019; 32(Suppl 1):4. PubMed ID: 30949283
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Seroprevalence of rubella infection after national immunization program in Taiwan: vaccination status and immigration impact.
    Wang IJ; Huang LM; Chen HH; Hwang KC; Chen CJ
    J Med Virol; 2007 Jan; 79(1):97-103. PubMed ID: 17133552
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rubella immune status among immigrant and nonimmigrant women in Spain.
    Ramos JM; Milla A; Rodríguez JC; Gutiérrez F
    J Med Virol; 2012 Mar; 84(3):548-50. PubMed ID: 22246845
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Congenital rubella syndrome due to infection after maternal antibody conversion with vaccine.
    Ushida M; Katow S; Furukawa S
    Jpn J Infect Dis; 2003 Apr; 56(2):68-9. PubMed ID: 12824690
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rubella vaccine: new horizon in prevention of congenital rubella syndrome in the India.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2012 Jun; 8(6):831-3. PubMed ID: 22495120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.